Skip to main content
. 2019 Jul 17;7:189. doi: 10.1186/s40425-019-0641-x

Fig. 5.

Fig. 5

“Prime/boost” gene signature from MIS416 Vax + MRB-OVA mapped to ovarian cancer patients from TCGA. a Heat map depicting unique 35 gene signature identified in MIS416 Vax + MRB-OVA treated tumors (n = 8–9). b Hierarchical clustering of ovarian cancer patients from TCGA based on expression of genes identified in a (n = 307). c Ovarian cancer patient survival based on individual clusters identified in b